With NIH “Accountability” As Background, Advocates Support Budget Increases.
Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.
Bush Nominates VA Official For HHS Deputy Secretary.
Stronger Anti-Smoking Efforts Needed For Women, SG Says.
Meharry, Vanderbilt Win Grant For Research Collaboration.
FDA Says Bristol’s UFT “Not Approvable” For Colorectal Cancer, Contrary To ODAC.
US Oncology Renegotiates Agreements To Operate Under Net Earnings Model.
Firm Begins Phase II Trial Of LDP-341 For Myeloma.
Faulding, NaPro In Agreement For Marketing Paclitaxel.
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
